{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:40:34Z","timestamp":1787319634026,"version":"build-2736575974"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014589","name":"Chief Scientist Office","doi-asserted-by":"publisher","award":["TCS\/18\/13"],"award-info":[{"award-number":["TCS\/18\/13"]}],"id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/21\/10559"],"award-info":[{"award-number":["PG\/21\/10559"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000589","name":"Chief Scientist Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000589","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.pharmthera.2023.108575","type":"journal-article","created":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T18:35:28Z","timestamp":1701628528000},"page":"108575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Hypertension &amp; dementia: Pathophysiology &amp; potential utility of antihypertensives in reducing disease burden"],"prefix":"10.1016","volume":"253","author":[{"given":"Mara","family":"Lyon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josie L.","family":"Fullerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine M.","family":"Work","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.pharmthera.2023.108575_bb0005","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nm0796-783","article-title":"Alzheimer\u2019s disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules","volume":"2","author":"Alonso","year":"1996","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108575_bb0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/1531-8249(200001)47:1<93::AID-ANA15>3.0.CO;2-8","article-title":"Assessment of cerebral blood flow in Alzheimer\u2019s disease by spin-labeled magnetic resonance imaging","volume":"47","author":"Alsop","year":"2000","journal-title":"Annals of Neurology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108575_bb0653","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1747-4949.2009.00387.x","article-title":"Oxidative stress and its role in the pathogenesis of ischaemic stroke","volume":"4","author":"Allen","year":"2009","journal-title":"Int J Stroke"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108575_bb0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004872-199610003-00006","article-title":"Vascular and neuronal hypertensive brain damage: Protective effect of treatment with Nicardipine","volume":"14","author":"Amenta","year":"1996","journal-title":"Journal of Hypertension. Supplement"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108575_bb0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1474-4422(10)70250-7","article-title":"Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: Analysis of data from the ONTARGET and TRANSCEND studies","volume":"10","author":"Anderson","year":"2011","journal-title":"Lancet Neurology"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108575_bb0025","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0895-7061(04)00863-5","article-title":"Calcium Channel blockade to prevent stroke in hypertension: A Meta-analysis of 13 studies with 103,793 subjects","volume":"17","author":"Angeli","year":"2004","journal-title":"American Journal of Hypertension"},{"issue":"19","key":"10.1016\/j.pharmthera.2023.108575_bb0030","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1001\/archinte.1994.00420190047006","article-title":"Impact of the treatment of isolated systolic hypertension on behavioral variables: Results from the systolic hypertension in the elderly program","volume":"154","author":"Applegate","year":"1994","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108575_bb0035","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1073\/pnas.90.2.567","article-title":"Alzheimer disease amyloid \u03b2 protein forms calcium channels in bilayer membranes: Blockade by Tromethamine and aluminum","volume":"90","author":"Arispe","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2023.108575_bb0040","series-title":"Cardiology explained","author":"Ashley","year":"2001"},{"key":"10.1016\/j.pharmthera.2023.108575_bb0045","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/jhh.2013.107","article-title":"The evidence for treating hypertension in older people with dementia: A systematic review","volume":"28","author":"Beishon","year":"2014","journal-title":"Journal of Human Hypertension"},{"key":"10.1016\/j.pharmthera.2023.108575_bb0050","series-title":"Journal of the","first-page":"1386","article-title":"Antihypertensive medication classes and the risk of dementia: A systematic review and network meta-analysis","volume":"22","author":"den Brok","year":"2021"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108575_bb0055","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0165-1838(94)90160-0","article-title":"Blood pressure regulation in Alzheimer\u2019s disease","volume":"48","author":"Burke","year":"1994","journal-title":"Journal of the Autonomic Nervous System"},{"issue":"MAY","key":"10.1016\/j.pharmthera.2023.108575_bb0060","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fnagi.2019.00108","article-title":"Calcium ions stimulate the hyperphosphorylation of tau by activating microsomal prostaglandin E synthase 1","volume":"11","author":"Cao","year":"2019","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108575_bb0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1475-2840-13-91","article-title":"Different angiotensin receptor blockers and incidence of diabetes: A nationwide population-based cohort study","volume":"13","author":"Chang","year":"2014","journal-title":"Cardiovascular Diabetology"},{"key":"10.1016\/j.pharmthera.2023.108575_bb0070","first-page":"1463","volume":"23","author":"Chiu","year":"2021"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108575_bb0075","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the joint mid-national committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"issue":"November 2018","key":"10.1016\/j.pharmthera.2023.108575_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2018.11.009","article-title":"Synthesis and antioxidant activity of new lipophilic Dihydropyridines","volume":"84","author":"da Costa Cabrera","year":"2019","journal-title":"Bioorganic Chemistry"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108575_bb0085","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1590\/1980-57642016dn11-040005","article-title":"Mixed dementia: A review of the evidence","volume":"11","author":"Custodio","year":"2017","journal-title":"Dementia & Neuropsychologia"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108575_bb0090","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial function and dysfunction: Testing and clinical relevance","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.pharmthera.2023.108575_bb0095","doi-asserted-by":"crossref","first-page":"10989","DOI":"10.1073\/pnas.90.23.10989","article-title":"Induction of apoptosis in cerebellar granule neurons by low potassium: Inhibition of death by insulin-like growth factor I and CAMP","volume":"90","author":"D\u2019Mello","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108575_bb0100","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/1715163517690745","article-title":"Dementia: What pharmacists need to know","volume":"150","author":"Duong","year":"2017","journal-title":"Canadian Pharmacists Journal"},{"issue":"15","key":"10.1016\/j.pharmthera.2023.108575_bb0105","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1074\/jbc.M607483200","article-title":"A\u03b2 oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug Memantine","volume":"282","author":"Felice","year":"2007","journal-title":"Journal of Biological Chemistry"},{"issue":"18","key":"10.1016\/j.pharmthera.2023.108575_bb0110","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1001\/archinte.162.18.2046","article-title":"The prevention of dementia with antihypertensive treatment: New evidence from the systolic hypertension in Europe (Syst-Eur) study","volume":"162","author":"Forette","year":"2002","journal-title":"Archives of Internal Medicine"},{"issue":"9137","key":"10.1016\/j.pharmthera.2023.108575_bb0115","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(98)03086-4","article-title":"Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial","volume":"352","author":"Forette","year":"1998","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108575_bb0120","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3390\/brainsci10120919","article-title":"Effects of blood pressure on cognitive performance in aging: A systematic review","volume":"10","author":"Forte","year":"2020","journal-title":"Brain Sciences. MDPI AG."},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108575_bb0125","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1161\/01.CIR.96.1.308","article-title":"Hemodynamic patterns of age-related changes in blood pressure: The Framingham heart study","volume":"96","author":"Franklin","year":"1997","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108575_bb0130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1741-7015-11-117","article-title":"Immunity, atherosclerosis and cardiovascular disease","volume":"11","author":"Frosteg\u00e5rd","year":"2013","journal-title":"BMC Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108575_bb0135","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1471-4159.2003.02020.x","article-title":"Alteration in calcium channel properties is responsible for the neurotoxic action of a familial frontotemporal dementia tau mutation","volume":"87","author":"Furukawa","year":"2003","journal-title":"Journal of Neurochemistry"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108575_bb0140","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1097\/00004872-200309000-00028","article-title":"The study on cognition and prognosis in the elderly (SCOPE): Principal results of a randomized double-blind intervention trial [1] (multiple letters)","volume":"21","author":"Gayet","year":"2003","journal-title":"Journal of Hypertension"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108575_bb0145","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1212\/WNL.0b013e3182a351d4","article-title":"Antihypertensive medication use and risk of cognitive impairment the Honolulu-Asia aging study","volume":"81","author":"Gelber","year":"2013","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108575_bb0150","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.neurobiolaging.2005.04.017","article-title":"Common mechanisms of amyloid oligomer pathogenesis in degenerative disease","volume":"27","author":"Glabe","year":"2006","journal-title":"Neurobiology of Aging"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108575_bb0155","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0006-8993(85)90680-8","article-title":"Autoradiographic localization of calcium channel antagonist receptors in rat brain with [3H]Nitrendipine","volume":"330","author":"Gould","year":"1985","journal-title":"Brain Research"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108575_bb0651","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038971","article-title":"Treatment of hypertension reduces cognitive decline in older adults: a systematic review and meta-analysis","volume":"10","author":"Gupta","year":"2020","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108575_bb0160","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/geronj\/39.2.166","article-title":"The SHORT-CARE: An efficient instrument for the assessment of depression, dementia and disability","volume":"39","author":"Gurland","year":"1984","journal-title":"Journal of Gerontology"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108575_bb0165","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jalz.2019.06.001","article-title":"Preventing dementia by preventing stroke: The Berlin manifesto","volume":"15","author":"Hachinski","year":"2019","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108575_bb0170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MNM.0b013e32804c58aa","article-title":"Favourable effects of Nilvadipine on cognitive function and regional cerebral blood flow on SPECT in hypertensive patients with mild cognitive impairment","volume":"28","author":"Hanyu","year":"2007","journal-title":"Nuclear Medicine Communications"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108575_bb0175","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1212\/01.WNL.0000129258.93137.4B","article-title":"Blood pressure and late-life cognitive function change: A biracial longitudinal population study","volume":"62","author":"Hebert","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2023.108575_bb0180","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4249","article-title":"Association of blood pressure lowering with incident dementia or cognitive impairment: A systematic review and meta-analysis","author":"Hughes","year":"2020","journal-title":"JAMA\u202f: The Journal of the American Medical Association"},{"issue":"3 SUPPL. 1","key":"10.1016\/j.pharmthera.2023.108575_bb0185","first-page":"S40","article-title":"Threats to the mind: Aging, amyloid, and hypertension","volume":"40","author":"Iadecola","year":"2009","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108575_bb0190","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3109\/10641969609081773","article-title":"High potassium diets reduce vascular and plasma lipid peroxides in stroke-prone spontaneously hypertensive rats","volume":"18","author":"Ishimitsu","year":"1996","journal-title":"Clinical and Experimental Hypertension"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108575_bb0195","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"The Lancet Neurology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108575_bb0200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/ars.2013.5669","article-title":"Neurovascular regulation in the ischemic brain","volume":"22","author":"Jackman","year":"2015","journal-title":"Antioxidants and Redox Signaling"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108575_bb0205","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jamaneurol.2013.217","article-title":"Blood pressure and progression of brain atrophy the SMART-MR study","volume":"70","author":"Jochemsen","year":"2013","journal-title":"JAMA Neurology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108575_bb0210","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jalz.2011.05.2414","article-title":"Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus","volume":"8","author":"Johnson","year":"2012","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108575_bb0215","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ics.2006.04.009","article-title":"Pattern of cerebral Hypoperfusion in Alzheimer\u2019s disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: Initial experience","volume":"1290","author":"Johnson","year":"2006","journal-title":"International Congress Series"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108575_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3988\/jcn.2006.2.1.1","article-title":"Small vessel disease and subcortical vascular dementia","volume":"2","author":"Kalaria","year":"2006","journal-title":"Journal of Clinical Neurology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108575_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1007168910582","article-title":"Intracellular calcium changes in neuronal cells induced by Alzheimer\u2019s \u03b2-amyloid protein are blocked by estradiol and cholesterol","volume":"21","author":"Kawahara","year":"2001","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108575_bb0230","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.arr.2008.11.001","article-title":"Blood pressure and the risk for dementia-a double edged sword","volume":"8","author":"Kennelly","year":"2009","journal-title":"Ageing Research Reviews"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108575_bb0235","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archneur.63.5.noc60013","article-title":"Antihypertensive medication use and incident Alzheimer disease: The Cache County study","volume":"63","author":"Khachaturian","year":"2006","journal-title":"Archives of Neurology"},{"issue":"7300","key":"10.1016\/j.pharmthera.2023.108575_bb0240","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","article-title":"Midlife vascular risk factors and Alzheimer\u2019s disease in later life: Longitudinal, population based study","volume":"322","author":"Kivipelto","year":"2001","journal-title":"British Medical Journal"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108575_bb0245","first-page":"432","article-title":"Circadian variation of blood pressure and heart rate in normotensives, White-coat, masked, treated and untreated hypertensives","volume":"53","author":"Koroboki","year":"2012","journal-title":"Hellenic Journal of Cardiology"},{"issue":"5\u20136","key":"10.1016\/j.pharmthera.2023.108575_bb0250","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0891-5849(99)00112-4","article-title":"Transendothelial permeability changes induced by free radicals in an in vitro model of the blood-brain barrier","volume":"27","author":"Lagrange","year":"1999","journal-title":"Free Radical Biology and Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108575_bb0255","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/1673-5374.228711","article-title":"Cerebral ischemia and Neuroregeneration","volume":"13","author":"Lee","year":"2018","journal-title":"Neural Regeneration Research"},{"key":"10.1016\/j.pharmthera.2023.108575_bb0260","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-190474","article-title":"Midlife hypertension and Alzheimer\u2019s disease: A systematic review and Meta-analysis","author":"Lennon","year":"2019","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108575_bb0265","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0197-4580(92)90010-U","article-title":"Old age and cognition: Enhancement of recent memory in aged rats by the calcium channel blocker Nimodipine","volume":"13","author":"Levere","year":"1992","journal-title":"Neurobiology of Aging"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108575_bb0270","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0091-3057(91)90164-W","article-title":"Nimodipine improves spatial working memory and elevates hippocampal acetylcholine in young rats","volume":"39","author":"Levy","year":"1991","journal-title":"Pharmacology, Biochemistry and Behavior"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108575_bb0275","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1532-5415.2007.01233.x","article-title":"Age-varying association between blood pressure and risk of dementia in those aged 65 and older: A community-based prospective cohort study","volume":"55","author":"Li","year":"2007","journal-title":"Journal of American Geriatrics Society"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108575_bb0280","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1568007054038210","article-title":"Preventing activation of receptor for advanced glycation Endproducts in Alzheimer\u2019s disease","volume":"4","author":"Lue","year":"2005","journal-title":"Current Drug Targets. CNS and Neurological Disorders"},{"key":"10.1016\/j.pharmthera.2023.108575_bb0285","series-title":"Alzheimer\u2019s research UK dementia statistics hub","author":"Luengo-Fernandez","year":"2022"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108575_bb0652","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer's disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nature reviews disease primers"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108575_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-018-2171-1","article-title":"The meaning of blood pressure Luigi Forni","volume":"22","author":"Magder","year":"2018","journal-title":"Critical Care"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108575_bb0295","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/HJH.0b013e3283603f53","article-title":"Antihypertensive classes, cognitive decline and incidence of dementia: A network Meta-analysis","volume":"31","author":"Marpillat","year":"2013","journal-title":"Journal of Hypertension"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108575_bb0300","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1046\/j.1471-4159.1999.721448.x","article-title":"Inhibition of excessive neuronal apoptosis by the calcium antagonist amlodipine and antioxidants in cerebellar granule cells","volume":"72","author":"Mason","year":"1999","journal-title":"Journal of Neurochemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108575_bb0305","doi-asserted-by":"crossref","first-page":"E142","DOI":"10.1212\/WNL.0000000000200521","article-title":"Determining vascular risk factors for dementia and dementia risk prediction across mid- to later life: The Framingham Heart Study","volume":"99","author":"McGrath","year":"2022","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108575_bb0310","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1212\/WNL.0000000000005810","article-title":"Author response: Blood pressure from mid- to late life and risk of incident dementia","volume":"91","author":"McGrath","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2023.108575_bb0315","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004034.pub3","article-title":"Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia","author":"McGuinness","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1 Supplement 1","key":"10.1016\/j.pharmthera.2023.108575_bb0320","first-page":"450","article-title":"Post-stroke cognitive impairment consensus report - a comprehensive update","volume":"2","author":"Mijajlovic","year":"2017","journal-title":"European Stroke Journal"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108575_bb0325","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global disparities of hypertension prevalence and control","volume":"134","author":"Mills","year":"2016","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108575_bb0330","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jpsychires.2008.04.014","article-title":"A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment","volume":"43","author":"Mitchell","year":"2009","journal-title":"Journal of Psychiatric Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108575_bb0335","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40885-019-0135-7","article-title":"Could management of blood pressure prevent dementia in the elderly?","volume":"25","author":"Mogi","year":"2019","journal-title":"Clinical Hypertension"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108575_bb0340","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2147\/VHRM.S2434","article-title":"Risk factors for vascular dementia: Hypotension as a key point","volume":"4","author":"Moretti","year":"2008","journal-title":"Vascular Health and Risk Management"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108575_bb0345","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/00044011-199611040-00001","article-title":"Nimodipine in the treatment of probable Alzheimer\u2019s disease: Results of two multicentre trials","volume":"11","author":"Morich","year":"1996","journal-title":"Clinical Drug Investigation"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108575_bb0350","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nrn3200","article-title":"The ageing cortical synapse: Hallmarks and implications for cognitive decline","volume":"13","author":"Morrison","year":"2012","journal-title":"Nature Reviews Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108575_bb0355","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0035-1555115","article-title":"The impact of age on cognition","volume":"36","author":"Murman","year":"2015","journal-title":"Seminars in Hearing"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108575_bb0360","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/gps.1874","article-title":"Diagnosing dementia - ICD-10 not so bad after all: A comparison between dementia criteria according to DSM-IV and ICD-10","volume":"23","author":"Naik","year":"2008","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1016\/j.pharmthera.2023.108575_bb0365","series-title":"Hypertension in adults: Diagnosis and Management NICE Guidelines [Online]","author":"National Institute for Health and Care Excellence (NICE)","year":"2019"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108575_bb0370","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF03325209","article-title":"Low systolic blood pressure is associated with impaired cognitive function in the oldest old: Longitudinal observations in a population-based sample 80 years and older","volume":"19","author":"Nilsson","year":"2007","journal-title":"Aging Clinical and Experimental Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108575_bb0375","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/HYPERTENSIONAHA.110.163055","article-title":"Midlife and late-life blood pressure and dementia in Japanese elderly: The Hisayama study","volume":"58","author":"Ninomiya","year":"2011","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108575_bb0380","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40885-018-0102-8","article-title":"Arterial stiffness and hypertension","volume":"24","author":"Oh","year":"2018","journal-title":"Clinical Hypertension"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108575_bb0385","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/HYPERTENSIONAHA.120.14993","article-title":"Blood pressure and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 209 prospective studies","volume":"76","author":"Ou","year":"2020","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108575_bb0390","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/HYPERTENSIONAHA.120.14993","article-title":"Blood pressure and risks of cognitive impairment and dementia: A systematic review and Meta-analysis of 209 prospective studies","volume":"76","author":"Ou","year":"2020","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108575_bb0395","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/j.1532-5415.2012.04061.x","article-title":"Self-reported dietary intake of potassium, calcium, and magnesium and risk of dementia in the Japanese: The Hisayama study","volume":"60","author":"Ozawa","year":"2012","journal-title":"Journal of the American Geriatrics Society"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108575_bb0400","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/01.STR.0000217653.01615.93","article-title":"Reducing the risk of dementia: Efficacy of long-term treatment of hypertension","volume":"37","author":"Peila","year":"2006","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108575_bb0405","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1474-4422(08)70143-1","article-title":"Incident dementia and blood pressure lowering in the hypertension in the very elderly trial cognitive function assessment (HYVET-COG): A double-blind, placebo controlled trial","volume":"7","author":"Peters","year":"2008","journal-title":"The Lancet Neurology"},{"issue":"976","key":"10.1016\/j.pharmthera.2023.108575_bb0410","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/pgmj.2006.048371","article-title":"Blood pressure and ageing","volume":"83","author":"Pinto","year":"2007","journal-title":"Postgraduate Medical Journal"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108575_bb0415","doi-asserted-by":"crossref","first-page":"H1598","DOI":"10.1152\/ajpheart.00490.2012","article-title":"The effects of hypertension on the cerebral circulation","volume":"304","author":"Pires","year":"2013","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2023.108575_bb0420","doi-asserted-by":"crossref","DOI":"10.1097\/EDE.0b013e31822708b5","article-title":"The association between blood pressure and incident Alzheimer disease: A systematic review and meta-analysis","author":"Power","year":"2011","journal-title":"Epidemiology"},{"issue":"7034","key":"10.1016\/j.pharmthera.2023.108575_bb0425","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/bmj.312.7034.801","article-title":"Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council\u2019s treatment trial of hypertension in older adults","volume":"312","author":"Prince","year":"1996","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108575_bb0430","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archneur.60.2.223","article-title":"Low blood pressure and risk of dementia in the Kungsholmen project: A 6-year follow-up study","volume":"60","author":"Qiu","year":"2003","journal-title":"Archives of Neurology"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108575_bb0435","first-page":"927","article-title":"Atherosclerosis: Process, indicators, risk factors and new hopes","volume":"5","author":"Rafieian-Kopaei","year":"2014","journal-title":"International Journal of Preventive Medicine"},{"key":"10.1016\/j.pharmthera.2023.108575_bb0440","doi-asserted-by":"crossref","DOI":"10.2174\/1386207323666201211101720","article-title":"Effect of antihypertensive drugs on cognition and behavioral symptoms of patients with Alzheimer\u2019s disease: A meta-analysis","author":"Rahimi","year":"2021","journal-title":"Current Pharmaceutical Biotechnology"},{"key":"10.1016\/j.pharmthera.2023.108575_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/8720904","article-title":"Social aspects of dementia prevention from a worldwide to national perspective: A review on the international situation and the example of Italy","volume":"2019","author":"Ricci","year":"2019","journal-title":"Behavioural Neurology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108575_bb0450","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2174\/1570159X15666170116143743","article-title":"The amyloid Cascade hypothesis in Alzheimer\u2019s disease: It\u2019s time to change our mind","volume":"15","author":"Ricciarelli","year":"2017","journal-title":"Current Neuropharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108575_bb0455","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1159\/000330020","article-title":"Vascular risk factors and dementia: 40-year follow-up of a population-based cohort","volume":"31","author":"Ronnemaa","year":"2011","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2023.108575_bb0460","first-page":"103","article-title":"Oxygen free radicals in essential hypertension","volume":"111","author":"Sagar","year":"1992","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108575_bb0465","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0197-4580(90)90120-O","article-title":"Aging and cognition: Facilitation of recent memory in aged nonhuman Primates by Nimodipine","volume":"11","author":"Sandin","year":"1990","journal-title":"Neurobiology of Aging"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108575_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108575_bb0475","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1113\/EP086434","article-title":"The role of the blood\u2013brain barrier in hypertension","volume":"103","author":"Setiadi","year":"2018","journal-title":"Experimental Physiology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108575_bb0480","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.amjopharm.2009.11.001","article-title":"Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review","volume":"7","author":"Shah","year":"2009","journal-title":"The American Journal of Geriatric Pharmacotherapy"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108575_bb0485","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/gps.2572","article-title":"Hypertension is a potential risk factor for vascular dementia: Systematic review","volume":"26","author":"Sharp","year":"2011","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"9009","key":"10.1016\/j.pharmthera.2023.108575_bb0490","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(96)90608-X","article-title":"15-year longitudinal study of blood pressure and dementia","volume":"347","author":"Skoog","year":"1996","journal-title":"Lancet"},{"issue":"6730","key":"10.1016\/j.pharmthera.2023.108575_bb0495","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/bmj.300.6730.981","article-title":"Control of blood pressure in Scotland: The rule of halves","volume":"300","author":"Smith","year":"1990","journal-title":"British Medical Journal"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108575_bb0500","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1212\/01.WNL.0000144281.38555.E3","article-title":"Vascular risk factors, incidence of MCI, and rates of progression to dementia","volume":"63","author":"Solfrizzi","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108575_bb0505","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/HYPERTENSIONAHA.109.128744","article-title":"Change in blood pressure and incident dementia: A 32-year prospective study","volume":"54","author":"Stewart","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2023.108575_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpsy.2017.07.015","article-title":"Effects of different antihypertensive medication groups on cognitive function in older patients: A systematic review","author":"Stuhec","year":"2017","journal-title":"European Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108575_bb0515","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1212\/WNL.51.4.986","article-title":"Association of midlife blood pressure to late-life cognitive decline and brain morphology","volume":"51","author":"Swan","year":"1998","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108575_bb0520","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/jcbfm.2014.44","article-title":"Cerebral hemodynamics in normal aging: Central artery stiffness, wave reflection, and pressure pulsatility","volume":"34","author":"Tarumi","year":"2014","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108575_bb0525","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer\u2019s disease: Synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2023.108575_bb0530","series-title":"Seminars in neurology","first-page":"167","article-title":"A comprehensive update on treatment of dementia","volume":"Vol. 39","author":"Tisher","year":"2019"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108575_bb0535","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/HJH.0000000000000868","article-title":"Diuretic antihypertensive drugs and incident dementia risk: A systematic review, Meta-analysis and Meta-regression of prospective studies","volume":"34","author":"Tully","year":"2016","journal-title":"Journal of Hypertension"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108575_bb0540","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","article-title":"Effects of blood pressure lowering with perindopril and Indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease","volume":"163","author":"Tzourio","year":"2003","journal-title":"Archives of Internal Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108575_bb0545","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1212\/WNL.53.9.1948","article-title":"Cognitive decline in individuals with high blood pressure: A longitudinal study in the elderly","volume":"53","author":"Tzourio","year":"1999","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108575_bb0550","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/ijcep.ijcep_43_17","article-title":"Potassium homeostasis, oxidative stress, and human disease","volume":"4","author":"Udensi","year":"2017","journal-title":"International Journal of Clinical and Experimental Physiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108575_bb0555","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1471-4159.1997.68010265.x","article-title":"Amyloid \u03b2 protein potentiates Ca2+ influx through L-type voltage- sensitive Ca2+ channels: A possible involvement of free radicals","volume":"68","author":"Ueda","year":"1997","journal-title":"Journal of Neurochemistry"},{"issue":"Suppl. 5","key":"10.1016\/j.pharmthera.2023.108575_bb0560","first-page":"2","article-title":"Epidemiology and risk factors of dementia","volume":"76","author":"Van Der Flier","year":"2005","journal-title":"Neurology in Practice"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108575_bb0565","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1097\/HJH.0000000000001411","article-title":"Lower dementia risk with different classes of antihypertensive medication in older patients","volume":"35","author":"Van Middelaar","year":"2017","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2023.108575_bb0570","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.expneurol.2015.05.006","article-title":"Models and mechanisms of vascular dementia","volume":"272","author":"Venkat","year":"2015","journal-title":"Experimental Neurology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108575_bb0575","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3233\/JAD-160527","article-title":"Stroke, vascular dementia, and Alzheimer\u2019s disease: Molecular links","volume":"54","author":"Vijayan","year":"2016","journal-title":"Journal of Alzheimer\u2019s Disease: JAD"},{"key":"10.1016\/j.pharmthera.2023.108575_bb0585","series-title":"Virtual international trials archive. (2017)","first-page":"2021","volume":"Vol. 1","author":"Vista","year":"2023"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108575_bb0590","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/ana.22516","article-title":"Cerebral amyloid angiopathy in the elderly","volume":"70","author":"Viswanathan","year":"2011","journal-title":"Annals of Neurology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108575_bb0595","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jama.2019.10575","article-title":"Association of Midlife to late-life blood pressure patterns with incident dementia","volume":"322","author":"Walker","year":"2019","journal-title":"Journal of the American Medical Association"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108575_bb0600","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3348\/kjr.2018.19.3.498","article-title":"Blood-brain barrier disruption and perivascular beta-amyloid accumulation in the brain of aged rats with spontaneous hypertension: Evaluation with dynamic contrast-enhanced magnetic resonance imaging","volume":"19","author":"Wang","year":"2018","journal-title":"Korean Journal of Radiology"},{"key":"10.1016\/j.pharmthera.2023.108575_bb0605","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2318-14-19","article-title":"The treatment of hypertension in people with dementia: A systematic review of observational studies","volume":"14","author":"Welsh","year":"2014","journal-title":"BMC Geriatrics"},{"key":"10.1016\/j.pharmthera.2023.108575_bb0610","series-title":"Hypertension [Online]","author":"WHO, World Health Organisation","year":"2019"},{"issue":"7440","key":"10.1016\/j.pharmthera.2023.108575_bb0615","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/bmj.328.7440.634","article-title":"British Hypertension Society Guidelines for Hypertension Management 2004 (BHS-IV): Summary","volume":"328","author":"Williams","year":"2004","journal-title":"British Medical Journal"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108575_bb0620","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/gps.4846","article-title":"Converting MMSE to MoCA and MoCA 5-minute protocol in an educationally heterogeneous sample with stroke or transient ischemic attack","volume":"33","author":"Wong","year":"2018","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108575_bb0625","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13041-018-0357-8","article-title":"Targeting Nmda receptors in stroke: New Hope in neuroprotection Tim Bliss","volume":"11","author":"Wu","year":"2018","journal-title":"Molecular Brain"},{"issue":"13","key":"10.1016\/j.pharmthera.2023.108575_bb0630","first-page":"1000","article-title":"Increased expression of receptor for advanced glycation end-products worsens focal brain ischemia in diabetic rats","volume":"7","author":"Xing","year":"2012","journal-title":"Neural Regeneration Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108575_bb0635","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1046\/j.1532-5415.2003.51117.x","article-title":"Association between dementia and midlife risk factors: The radiation effects research foundation adult health study","volume":"51","author":"Yamada","year":"2003","journal-title":"Journal of the American Geriatrics Society"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108575_bb0640","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neurobiolaging.2004.03.009","article-title":"Calcium Channel blockers and risk of AD: The Baltimore longitudinal study of aging","volume":"26","author":"Yasar","year":"2005","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2023.108575_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2013.07.809","article-title":"Expression profile of MicroRNAs in the peripheral lymphocyte of acute stroke patients","volume":"333","author":"Zhao","year":"2013","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2023.108575_bb0650","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007858.pub2","article-title":"Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient Ischaemic attack","author":"Zonneveld","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823002395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823002395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:38:49Z","timestamp":1759012729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725823002395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":132,"alternative-id":["S0163725823002395"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108575","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertension & dementia: Pathophysiology & potential utility of antihypertensives in reducing disease burden","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108575","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108575"}}